“Clinical Uses of Hemp Extracts in the treatment of Osteoarthritis in dogs and Emerging Evidence in their use in the treatment of Neuropathic & Acute Pain States”
Wednesday 10th March 2021 8pm.
“Clinical Uses of Hemp Extracts in the treatment of Osteoarthritis in dogs and Emerging Evidence in their use in the treatment of Neuropathic & Acute Pain States”
Wednesday 10th March 2021 8pm.
March 2021 We now have COVID-19 antibody and antigen rapid test devices available to order from our warehouse. They are both in vitro immunoassays providing direct and qualitative results.
The Antibody test detects SARS-CoV-2 IgG and IgM in human whole blood, serum or plasma.
The Antigen test detects viral nucleoprotein antigens from the nasopharyngeal secretions and oropharyngeal secretions.
February 2021.
Please visit The Webinar Vet to see the following CBD webinars sponsored by ElleVance Sciences.
January 2021.
HIGH QUALITY and SCIENTIFICALLY TESTED complete spectrum hemp CBD+CBDA products made by ElleVance Sciences. All products are manufactured in Colorado, USA and imported to the UK by Merlin Vet. We are the sole distributor for Ellevance Sciences full veterinary product range for the UK veterinary market.
Please note these products are only available to UK veterinary surgeons who adhere to the Prescribing Cascade set out by the VMD.
Introducing the first product from the Resolvet line of horse care products. Created by veterinarians from Hagyard Equine Medical Institute.
Relyne GI capitalizes on the dual benefit of a patented stomach buffering hyaluronan and the immune boosting effects of a beta-glucan to maintain a healthy digestive system.
Presented by Nathan Slovis DVM, Dipl. ACVIM, CHT
The Veterinary Team at Hagyard Equine Medical Institute in Lexington, Kentucky has discovered the potency of a polysaccharide formula targeting Equine Gastric Ulcer Syndrome (EGUS). Previous pre-clinical successes with other species drove their investigation.
As you know, the prevalence of gastric ulcers in horses is high across all disciplines and effects overall condition, performance, and behaviour. The Hagyards Veterinary team sought an alternative to traditional treatment options for EGUS that would be effective and safe for continuous use without altering the GI pH.
Join us to hear how their investigations and continued field-use have resulted in the creation of Relyne GI.
A blend of high molecular weight Hyaluronic Acid & yeast extract formulated to support gastric health in horses. Recommended and used by veterinary surgeons and professional horsemen, Resolvet Relyne GI is the choice for natural gastric support.
November 2020: Antepsin solution is now available from our UK warehouse.
Antepsin Solution 200ml (Sucralfate 20%) (Italy) now available to all UK veterinary surgeons from our UK warehouse. Order online today!
October 2020: Relyne GI is now available from our UK warehouse.
A blend of high molecular weight Hyaluronic Acid & yeast extract formulated to support gastric health in horses. Recommended and used by veterinary surgeons and professional horsemen, Resolvet Relyne GI is the choice for natural gastric support.
September 2020: Dectomax Injection is now available from our UK warehouse.
Dectomax injectable (Doramectin 10mg/ml) now available to all UK veterinary surgeons from our UK warehouse. Order online today!
We stock an extensive range of Special Import Products. These all require a valid Special Import Certificate – SIC – to enable us to supply the product to our client (registered UK veterinary surgeons only). This is easily applied for using the online VMD (Veterinary Medicines Directorate) Special Import Scheme Home Page.
All our registered veterinary surgeons are reminded that the prescribing vet is personally responsible for the choice of product and, as part of the Royal College of Veterinary Surgeons (RCVS) Code of Professional Conduct for Veterinary Surgeons, must obtain the owner’s consent for their animal to be treated under the cascade. They must also maintain accurate records.
A withdrawal period is the length of time that must lapse between the final administration of the medicine and the point the animal can be slaughtered to enter the food chain or when produce is taken.
The prescribing vet is required to specify an appropriate withdrawal period when prescribing or administering a medicine to food-producing animals under the cascade. When setting the withdrawal period, the vet must take into account known information about the use of the product on the authorised species when prescribing for another species.
If a product is used as authorised, for example, use of an imported product from another member state, the authorised withdrawal period should be followed.
Where the product is not used as authorised, for example, when a higher dose is used, or a species for which the product is not indicated is treated, then care needs to be taken to ensure that a suitable withdrawal period is set. This ensures that no residues of veterinary medicines above the maximum residue limit remain at the time of slaughter or when produce is taken.
The minimum statutory withdrawal periods are:
However, in cases where the authorised withdrawal periods are close to, or longer than, the ‘statutory minimum’ withdrawal periods, the vet should consider other factors when setting a suitable withdrawal period. Factors to consider include:
The vet could, for example, increase the authorised withdrawal period by 50% (where a 30 day withdrawal period is authorised in cattle (meat and offal), a 45 day withdrawal period might be suitable for goats). If a higher dose is given, then a longer period may be warranted.
(Please see the VMD website for full details on prescribing.)